The Drug Controller General of India has suspended the licence for PresVu eye drops from Entod Pharmaceuticals over unauthorised promotion and safety concerns. Entod plans to challenge this, citing successful clinical trials and noting that similar products have been approved in the US without any serious issues.
Related Posts
iPhone 16 launch: What changes to expect for Apple iPhone 16 and iPhone 16 Plus
Apple is expected to launch the iPhone 16 series at the ‘It’s Glowtime’ event on September 9. The lineup will feature four models: iPhone 16, […]
Elon Musk calls German Christmas market attack ‘Deliberate mass murder’
Elon Musk called for German Chancellor Olaf Scholz’s resignation following a deadly car attack at a Christmas market in Magdeburg, Germany. A driver plowed into […]
Bitcoin hits $100,000-mark: How China lost crypto race to US and Trump
Bitcoin smashed the $100,000 barrier, fueled by Trump’s pro-cryptocurrency stance and his appointment of advocate Paul Atkins to the SEC. This win signifies a US […]